Drug Discovery Services For US Clients

We work routinely with international clients through clear contractual frameworks, direct scientific communication, and time-zone aligned scheduling. Our scientists regularly engage with US partners through virtual meetings and conferences, and in-person meetings can be arranged when appropriate. Clients are also welcome to visit our UK facilities during active programs.

Yes. We regularly support early-stage and venture-backed US biotechs. Our teams design studies aligned to early discovery objectives, helping to de-risk programs and generate data suitable for internal decision-making, funding milestones, licensing discussions, or publication.

We manage international sample shipping and logistics, including customs documentation, tracking, and compliance with relevant biosafety requirements. We can work with your preferred courier or recommend established shipping routes based on sample type and project needs.

Yes. All intellectual property remains with the client. We operate under international standard CDAs and MSAs, supported by strict confidentiality policies, auditable records, and secure data storage. Client data and methods are never shared across projects.

Yes. We can format and deliver assay data to integrate with platforms such as Dotmatics, ActivityBase, and related systems. We also provide structured datasets, QC metrics, and raw data to support downstream analysis, modeling, and internal data workflows.

Project initiation typically occurs within 2-4 weeks of proposal, depending on study scope and material availability. We support early scoping discussions and can provide initial SoW suggestions to help define study objectives, timelines, and deliverables, enabling efficient project setup and onboarding.